Nature Chemical BiologySynthetic BiologyPeer-reviewed journal article
Conversion of natural cytokine receptors into orthogonal synthetic biosensors
Hailey I. EdelsteiniD, Amparo CosioiD, Max L. Ezekiel, William K. CorcoraniD, Aaron H. MorrisiD, Joshua N. LeonardiD
Abstract
Synthetic receptors enable bioengineers to build cell-based therapies that perform therapeutic functions in a targeted or conditional fashion to enhance specificity and efficacy. Although many synthetic receptors exist, it remains challenging to generate new receptors that sense soluble cues and relay that detection through orthogonal mechanisms independent of native pathways. Towards this goal, we investigated co-opting natural cytokine receptor ectodomains into Modular Extracellular Sensor Architecture receptors (yielding natural ectodomain, NatE MESA receptors). We generated multiple high-performing, orthogonal synthetic cytokine receptors, identified design principles and constraints, and propose guidance for extending this approach to other natural receptors. We demonstrate utility of NatE MESA by engineering T cells to sense an immunosuppressive cue and respond with customized transcriptional output to support CAR T-cell activity. Finally, we multiplex NatE MESA to logically evaluate multiple cues associated with the tumor microenvironment. These technologies and learnings will enable engineering cellular functions for new applications.
- Citations
- 11
- FWCI
- 4.53
- Field percentile
- top 4%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Engineered Receptors for Soluble Cell-to-Cell Communication
Dan Ilya Piraner, Mohamad H. Abedi, … Kole T. Roybal·NaturePeer-reviewed·Nov 14, 2024
- Elucidation and refinement of synthetic receptor mechanisms
Hailey I. Edelstein, Patrick S. Donahue, … Joshua N. Leonard·Synthetic BiologyPeer-reviewed·Jan 1, 2020
- Design and modular assembly of synthetic intramembrane proteolysis receptors for custom gene regulation in therapeutic cells
Iowis Zhu, Raymond Liu, … Kole T. Roybal·CellPeer-reviewed·Apr 1, 2022
- Engineered cells that sense and respond to interleukin-23 with neutralizing therapy for autoimmunity
Gabriela Garza, Sonja Danon, … Aaron H. Morris·bioRxiv·Oct 14, 2026
- Synthetic Cytosolic Splicing Enables Programmable mRNA-Encoded Receptors
Matteo Lampis, Yaakov Benenson·bioRxiv·Apr 27, 2025
- IL-9 as a naturally orthogonal cytokine with optimal JAK/STAT signaling for engineered T cell therapy
Hua Jiang, Sam P. Limsuwannarot, … Anusha K. Kalbasi·ImmunityPeer-reviewed·Nov 21, 2025